Association of the serotonin transporter promoter polymorphism with suicidal behavior (original) (raw)

Molecular Psychiatry volume 8, pages 899–900 (2003)Cite this article

SIR – The potential role of the functional polymorphism in the regulatory region of the serotonin transporter gene (5-HTTLPR) in suicidal behavior has been a matter of controversy. Since suicidal behavior is a complex, multideterminated phenomenon, we hypothesized that the conflicting results may be explained by differences in characterization of suicide attempts. Thus, a detailed phenotypic characterization of the suicide attempt is of major interest given that a biological factor could play a major role in some categories of suicidal behavior (eg violent or impulsive or more lethal or repetitive ones) but not in every one. We have previously found an association between lower serotonergic function and suicidal behavior in major depressed1 and schizophrenic patients.2 Thus, to test this hypothesis we investigated the 5-HTTLPR polymorphism in a well-characterized sample of in-patients, subgrouped according to lifetime suicide behavior characteristics and in a sample of healthy controls.

Patients with consecutive admissions, diagnosed according to the DSM-IV criteria based on a structured interview,3 with recurrent major depression (_n_=106) or schizophrenia (_n_=131) were enrolled. Healthy controls, without history of suicide, (_n_=75, staff or faculty members) were interviewed and were free of psychiatric illness, with no familial history of axis I psychiatric disorder up to first-degree relatives.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$259.00 per year

only $21.58 per issue

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

References

  1. Corrêa H et al. Psychiatry Res 2000; 93: 189–199.
  2. Corrêa H et al. Schizophr Res 2002; 56: 75–85.
  3. M.I.N.I.-PLUS- Mini International Neuropsychiatric Interview. Brazilian version 5.0.0. 2000, Brasil, Edited by Amorim P.
  4. Malone KM et al. Am J Psychiatry 1995; 152: 1601–1607.
  5. Beck RW et al. Psychol Rep 1974; 34: 445–446.
    Article CAS Google Scholar
  6. Correa H et al. Cell Mol Neurobiol 2002; 22: 813–817.
  7. Lesch KP et al. Science 1996; 274: 1527–1530.
    Article CAS Google Scholar
  8. Parra FC et al. Proc Natl Acad Sci USA 2003; 7:177–182.

Download references

Author information

Authors and Affiliations

  1. Laboratório de Farmacogenética, ICB, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil
    A C Campi-Azevedo, W Boson, L De Marco, M A Romano-Silva & H Correa
  2. Departamento de Farmacologia, ICB, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil
    L De Marco & M A Romano-Silva
  3. Departamento de Morfologia, ICB, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil
    H Correa
  4. Grupo de Pesquisa em Neuropsiquiatria Clínica e Molecular, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil
    A C Campi-Azevedo, M A Romano-Silva & H Correa

Authors

  1. A C Campi-Azevedo
  2. W Boson
  3. L De Marco
  4. M A Romano-Silva
  5. H Correa

Corresponding author

Correspondence toH Correa.

Rights and permissions

About this article

Cite this article

Campi-Azevedo, A., Boson, W., De Marco, L. et al. Association of the serotonin transporter promoter polymorphism with suicidal behavior.Mol Psychiatry 8, 899–900 (2003). https://doi.org/10.1038/sj.mp.4001381

Download citation

This article is cited by